Cancer Related News
A new, highly accurate prostate cancer test has been developed
Researchers have developed a new prostate cancer test, which can detect the disease more accurately than current methods.
Research showed that the prostate cancer test...
Poor metabolic health can increase the risk of obesity-related cancer
Research has shown that people with poor metabolic health are at a greater risk of certain forms of cancer, regardless of their body weight.
A...
New CAR T-cell therapy offers new hope to ovarian cancer patients
CAR T-cell therapy has shown to be effective in mice with ovarian cancer, offering new hope to patients who require effective treatment.
CAR T-cell therapy...
Defence Therapeutics begins manufacturing of it’s ARM vaccine
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the start...
Researchers identify new treatment options for uveal melanoma
Researchers have found a candidate drug and biomarker that could be used to treat uveal melanoma, a rare eye cancer.
Uveal melanoma (UM) is a...
Researchers discover the mechanism behind lung adenocarcinoma
Researchers have found the mechanism responsible for the development of cancer-associated fibroblasts which are essential to lung adenocarcinoma.
Lung adenocarcinoma is a common form of...
Ultra-processed foods have been linked to an increased risk of cancer
High consumption of ultra-processed foods could lead to an increased risk of cancer, according to a new study from Imperial College London (ICL).
The new...
New research says actin plays a key role in the spread of cancer
Researchers from the University of Freiburg found that the release of so-called prometastatic factors is influenced by proteins in the cells’ skeleton called actin.
According...
An existing drug could provide a potent treatment for acute leukaemia
Researchers from the National University of Singapore (NUS) have revisited an existing drug that they believe could treat acute leukaemia.
The drug is called PIK-75...
How loyalty card data could identify symptoms of ovarian cancer sooner
Loyalty card data from over-the-counter medicine purchases could help spot symptoms of ovarian cancer sooner.
Imperial College London researchers explored whether there is a link...
More than 400 people will benefit from CAR-T therapy NICE approval
Over 400 people with an aggressive form of lymphoma are set to benefit from the first CAR-T therapy recommended for routine use in the...
Defence Therapeutics has melanoma vaccine validated
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation...
Chemotherapy before surgery reduces the risk of colon cancer returning
Cancer Research UK finds that giving colon cancer patients chemotherapy before surgery cuts their risk of the disease returning.
In a new Cancer Research UK-funded...
Researchers develop new precision therapy for bile duct cancer
University College London (UCL) researchers have developed a precision therapy for bile duct cancer that extends patients’ lives.
Bile duct cancer is cancer that’s found...
Defence Therapeutics has US patent accepted for Accum
Defence Therapeutics Inc, a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies including Antibody Drug Conjugate...
Defence Therapeutics launch Accum-mRNA vaccine programme
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the advancement...
Vitamin D supplements can reduce the risk of melanoma
Fewer cases of melanoma were found in regular users of vitamin D supplements than in non-users, according to a new study.
People who regularly take...
A new biomarker can measure CAR-T cell therapy response
Researchers have discovered a potent biomarker for clinical responses to CAR-T cell therapy that could improve lymphoma treatment.
The findings from MedUni Vienna could provide...
Personalising brachytherapy for better results against cervical cancer
A study from MedUni Vienna and Vienna General Hospital has demonstrated the benefits of a targeted approach in brachytherapy to treat cervical cancer.
Researchers from...
NHS cancer treatment rates are highest on record in 2022
Figures show that over 320,000 people received NHS cancer treatment from November 2021 to October 2022 – the highest year on record.
To start the...
